Newark, New Castle, USA, April 19, 2023 (GLOBE NEWSWIRE) -- According to a recent Growth Plus Reports study, the Acne Treatment Market is estimated to hit US$ 13.64 billion by 2030, with a revenue CAGR of 4.60%. The study provides insights into the important strategies, drivers, opportunities, competition, market dynamics, data, forecasts, and important regions.
Key Takeaways:
- The increasing prevalence of acne in youngsters will drive market revenue growth.
- Increasing regulatory approval for new acne treatment drugs will support the acne treatment market's revenue growth.
- North America dominates the global acne treatment market.
Request a Free Sample of the Research Report: https://www.growthplusreports.com/inquiry/request-sample/acne-treatment-market/7927
Acne Treatment Market Scope
Report Attribute | Details |
Market size value in 2021 | US$ 9.1 billion |
Revenue forecast in 2030 | US$ 13.64 billion |
Growth Rate | CAGR of 4.60% from 2022 to 2030 |
Base year for estimation | 2021 |
Forecast period | 2022-2030 |
Segments covered | Drug, Route of administration, distribution channel, and region. |
Regional scope | North America, Europe, Asia Pacific, and the Rest of the World (ROW) |
Market Drivers
The growth in the prevalence of acne amongst teenagers will drive the revenue growth of the acne treatment market. Furthermore, increasing R&D expenditure, growing social media influence, increasing number of authorized medications, and the launch of novel drugs are expected to boost the market revenue growth rate. Additionally, an increase in dermatologists and skin care clinics is expected to support the market's revenue growth.
Market Segmentation
Growth Plus Reports has analyzed the acne treatment market from five perspectives: Drug, Drug Type, Route of Administration, Distribution Channel, and Region.
Drug Segmentation: Based on the drug, the global acne treatment market is segmented into retinoids, antibiotics, isotretinoin, and others. The antibiotics segment accounts for the largest revenue share because of the increasing approval of antibiotic drugs for acne treatment and their high efficacy and long-term therapeutic effect.
Drug Type Segmentation: Based on the drug type, the acne treatment market is segmented into over-the-counter (OTC) and prescription. The over-the-counter (OTC) segment dominates the market because of its easy accessibility to drugs, low cost, time-saving, no need for a prescription, and high efficacy.
Route of Administration Segmentation: Based on the route of administration, the acne treatment market is segmented into oral, topical, and injectable. The topical segment dominates the market because it is a safe route with a direct site of action and a high therapeutic effect.
Distribution Channel Segmentation: Based on the distribution channel, the acne treatment market is segmented into hospital pharmacies and retail & online pharmacies. The retail & online pharmacy segment dominates the market because of the increasing number of retail & online pharmacies, ease of accessibility, and
cost-effectiveness.
Regional Growth Dynamics
Based on the region, the acne treatment market is segmented into North America, Europe, Asia Pacific, and the Rest of the World.
North America dominates the global acne treatment market with the largest revenue share. The region's high disposable income, rising acne treatment-approved drugs, and widespread adoption of novel treatments are attributed to its significant revenue share in the global market.
Request for Customization – https://www.growthplusreports.com/inquiry/customization/acne-treatment-market/7927
Competitive Landscape
The key players in the global acne treatment market are:
· Charles River Laboratories International, Inc.
· Clean Cells
· Eurofins Scientific SE
· Kedrion S.p.A.
· Merck KGaA
· Sartorius AG
· Texcell SA
· Vironova AB
· ViruSure GmbH
· WuXi Biologics
The market for acne treatment is slightly competitive, with several multinational companies involved. To enhance their market position, major competitors engage in technological advancements, R&D, and mergers and acquisitions.
Recent developments:
· Glenmark Pharma, under the trade name MINYM, introduced the first topical minocycline 4% gel in India in July 2022 to treat severe to moderate acne.
· During the American Academy of Dermatology Annual Meeting in March 2022, Galderma launched TWYNEO Cream in the United States to treat facial acne, which will be commercially available in spring.
· VYNE Therapeutics, Inc. acquired two FDA-approved topical minocycline products and the molecule Stabilizing Technology (MST) Franchise to Journey Medical Corporation in January 2022. This franchise includes AMZEEQ, which is used to treat acne.
Table of Content
- INTRODUCTION
- Market Ecosystem
- Timeline Under Consideration
- Historical Years – 2020
- Base Year – 2021
- Forecasted Years – 2022 to 2030
- Currency Used in the Report
- RESEARCH METHODOLOGY
- Research Approach
- Data Collection Methodology
- Data Sources
- Secondary Sources
- Primary Sources
- Market Estimation Approach
- Bottom Up
- Top Down
- Market Forecasting Model
- Limitations and Assumptions
- PREMIUM INSIGHTS
- Current Market Trends (COVID-19 Perspective)
- Key Players & Competitive Positioning (2021)
- MARKET DYNAMICS
- Drivers
- Restraints/Challenges
- Opportunities
- GLOBAL ACNE TREATMENT MARKET - ANALYSIS & FORECAST, BY DRUG
- Retinoids
- Antibiotics
- Isotretinoin
- Others
- GLOBAL ACNE TREATMENT MARKET - ANALYSIS & FORECAST, BY DRUG TYPE
- OTC
- Prescription
- GLOBAL ACNE TREATMENT MARKET - ANALYSIS & FORECAST, BY ROUTE OF ADMINISTRATION
- Oral
- Topical
- Injectable
- GLOBAL ACNE TREATMENT MARKET - ANALYSIS & FORECAST, BY DISTRIBUTION CHANNEL
- Hospital Pharmacies
- Retail & Online Pharmacies
Buy this Premium Research Report: https://www.growthplusreports.com/checkout-7927
VALUE PROPOSITIONS RELATED TO THE REPORT:
- Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
- Comprehensive quantitative and qualitative insights at segment and sub-segment level
- Covid 19 impact trends and perspective
- Granular insights at global/regional/country level
- Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
- Blanket coverage on competitive landscape
- Winning imperatives
- Exhaustive coverage on 'Strategic Developments' registered by leading players of the market
CUSTOMIZATION OPTIONS:
- Distributor Landscape Assessment
- Pricing Intelligence
- Customer Base Assessment
- Investment & Initiatives Analysis
- 'Business Profile' of Key Players
Schedule a call with our analyst: https://appoint.ly/s/salesZ3Jvd3RocGx1c3JlcG9ydHMuY29t/introduction
Visit our report store at - https://www.growthplusreports.com/report-store
Browse Latest Healthcare Related Reports:
Pertussis Market by Treatment (Immunization, Antibiotics), Patient Type (Pediatric, Adults) – Global Outlook & Forecast 2023-2031
Beta Thalassemia Market by Treatment (Erythroid Maturation Agents, Iron Chelating Drugs, Stem Cell Therapy, Others) Indication (Beta Thalassemia Minor, Beta Thalassemia Intermedia, Beta Thalassemia Major) – Global Outlook & Forecast 2023-2031
NGS Automation Market by Product (Workstation/Robotic Platform, Reagents & Consumables), Application (Drug Discovery, Clinical Diagnostics, and Others), End User (Hospitals & Diagnostic Laboratories) – Global Outlook & Forecast 2023-2031
Pulmonary Valve Replacement Market by Valve (Biological Valve, Mechanical Valve), Application (Pulmonary Valve Stenosis), End User (Ambulatory Surgical Centers, hospitals) - Global Outlook and Forecast 2023-2031
Molluscum Contagiosum Treatment Market by Treatment Type (Cryotherapy, Curettage, Laser Therapy, Topical Treatment), End User (Hospitals, Dermatology Clinics) - Global Outlook and Forecast 2023-2031
About Us:
Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).
Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.
We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.